Literature DB >> 12976081

[Combined application of local anesthetics and pyrazolon derivatives in rheumatism].

G K KRAUCHER.   

Abstract

Entities:  

Keywords:  ANALGESICS/therapeutic use; RHEUMATISM/therapy

Mesh:

Substances:

Year:  1952        PMID: 12976081     DOI: 10.1007/BF01236402

Source DB:  PubMed          Journal:  Acta Neuroveg (Wien)        ISSN: 0375-9245


× No keyword cloud information.
  36 in total

1.  [Antiphlogistic effect of pyrazols, especially of irgapyrin, in peroral and parenteral administration].

Authors:  G WILHELMI
Journal:  Schweiz Med Wochenschr       Date:  1950-09-02

2.  [Not Available].

Authors:  G WILHELMI
Journal:  Schweiz Med Wochenschr       Date:  1949-06-25

3.  [On irgapyrine, a new drug in parenteral pyrazol therapy of rheumatic polyarthritis].

Authors:  H FISCHER
Journal:  Dtsch Med Wochenschr       Date:  1951-01-12       Impact factor: 0.628

4.  [Problem of rheumatism; unified concept and marked therapeutic results with modern diagnostic therapeutic methods].

Authors:  M G GOOD
Journal:  Dtsch Med Wochenschr       Date:  1951-06-22       Impact factor: 0.628

5.  [Results of hypophysis implantations in disease of the blood].

Authors:  K FELLINGER; E E REIMER
Journal:  Med Klin       Date:  1951-03-30

6.  [Further data on intravenous application of local anesthetics in ulcer therapy].

Authors:  G K KRAUCHER
Journal:  Arztl Wochensch       Date:  1951-05-25

7.  [Treatment of polyarthritis with nitrogen mustard].

Authors:  H FLEISCHHACKER; H DITTRICH
Journal:  Med Klin       Date:  1951-04-20

8.  [Use of novocain in internal medicine. I. Pharmacology].

Authors:  F EICHHOLTZ
Journal:  Klin Wochenschr       Date:  1950-12-01

9.  [Pituitary implantation].

Authors:  K FELLINGER; F KAINDL; J SCHMID
Journal:  Wien Z Inn Med       Date:  1950-08

10.  [Comparative study of parenteral pyramidon therapy, with special reference to chronic rheumatoid arthritis].

Authors:  W H FAHNDRICH; J JUNKERSDORF
Journal:  Dtsch Med Wochenschr       Date:  1950-09-01       Impact factor: 0.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.